The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Five-year follow-up of ELEVATE-TN.
 
Jeff Porter Sharman
Employment - US Oncology Network
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Beigene; Beigene; Bristol-Myers Squibb; Genentech; Merck; TG Therapeutics
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
 
Miklos Egyed
No Relationships to Disclose
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; Debiopharm Group; Epizyme; Janssen-Cilag; Roche
Research Funding - Acerta Pharma; Bayer; BeiGene; Debiopharm Group; Epizyme; Incyte; Janssen-Cilag; MEI Pharma; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics
 
Alan P. Skarbnik
Honoraria - Abbvie; AstraZeneca; BeiGene; Celgene; Genentech; Jazz Pharmaceuticals; Kite, a Gilead company; MorphoSys; Pharmacyclics/Janssen; TG Therapeutics
Consulting or Advisory Role - Celgene; Genentech/Abbvie; Pharmacyclics/Janssen; TG Therapeutics
Speakers' Bureau - Abbvie/Genentech; AstraZeneca; BeiGene; Jazz Pharmaceuticals; Kite, a Gilead company; Pharmacyclics/Janssen; TG Therapeutics
Research Funding - Ascentage Pharma (Inst); AstraZeneca (Inst); Cyclacel (Inst); Genentech/Roche (Inst); Janssen (Inst); Juno Therapeutics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BeiGene; Genentech/Abbvie
 
Manali K. Kamdar
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca; BeiGene; Celgene
Speakers' Bureau - Seagen
Research Funding - Genentech; Novartis; TG Therapeutics (Inst)
 
Talha Munir
Honoraria - Abbvie; Alexion Pharmaceuticals; AstraZeneca; Janssen; Sobi
Consulting or Advisory Role - AbbVie; Alexion Pharmaceuticals; AstraZeneca; Janssen; Roche; Sobi
Speakers' Bureau - AbbVie; Alexion Pharmaceuticals; Apellis Pharmaceuticals; AstraZeneca; Janssen
Travel, Accommodations, Expenses - AbbVie; AstraZeneca
 
Laura Fogliatto
No Relationships to Disclose
 
Yair Herishanu
Honoraria - Abbvie; AstraZeneca/MedImmune; Janssen; Medison; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; BeiGene; Janssen
 
Versha Banerji
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Janssen
Speakers' Bureau - Abbvie; AstraZeneca; Janssen
Patents, Royalties, Other Intellectual Property - Biogene
 
George Follows
Stock and Other Ownership Interests - Centessa Pharmaceuticals
Honoraria - Abbvie; AstraZeneca; Centessa Pharmaceuticals; Janssen; Roche
Consulting or Advisory Role - AbbVie; AstraZeneca; Centessa Pharmaceuticals; Janssen; Roche
Speakers' Bureau - Abbvie; AstraZeneca; Centessa Pharmaceuticals; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Centessa Pharmaceuticals; Janssen; Roche; Takeda
 
Patricia Walker
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - Roche
 
Karin Karlsson
No Relationships to Disclose
 
Paolo Ghia
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; ArQule; BeiGene; Dynamo Therapeutics; Gilead Sciences; Janssen Oncology; Juno Therapeutics; Juno/Celgene/Bristol-Myers Squibb; Lilly; MEI Pharma; MSD; Roche; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; ArQule; BeiGene; Dynamo Therapeutics; Gilead Sciences; Janssen; Juno Therapeutics; Lilly; MEI Pharma; MSD; Roche; Sunesis Pharmaceuticals
Research Funding - Abbvie; AstraZeneca; Gilead Sciences; Janssen Oncology; Novartis; Sunesis Pharmaceuticals
 
Ann Janssens
Consulting or Advisory Role - AbbVie; Amgen; AstraZeneca; Janssen; MSD; Novartis; Sandoz; Sanofi; Sobi
Speakers' Bureau - Amgen; AstraZeneca; Incyte; Janssen; Novartis; Sobi; Takeda
 
Emmanuelle Ferrant
Honoraria - Abbvie; AstraZeneca; Gilead Sciences; Janssen
Consulting or Advisory Role - Abbvie; AstraZeneca; Gilead Sciences; Janssen
 
Veerendra Munugalavadla
Employment - AstraZeneca; Gilead Sciences (I)
Stock and Other Ownership Interests - AstraZeneca Canada; Gilead Sciences
 
Ting Yu
Employment - AstraZeneca
Stock and Other Ownership Interests - Abbott; AbbVie; AstraZeneca; Johnson & Johnson
 
Min Hui Wang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Jennifer Ann Woyach
Consulting or Advisory Role - AstraZeneca; Beigene; Genentech; Janssen; Loxo; Newave Pharmaceutical; Pharmacyclics
Research Funding - Abbvie; Janssen; Karyopharm Therapeutics; MorphoSys; Schrodinger